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Authors should submit three (3) hardcopies of their paper although
wherever possible, electronic manuscripts only may be submitted in
double-spaced typing, by E-Mail as an attachment in Word with the
tables, figures and illustrations in Word, PowerPoint or as JPEG files.
Whether hard copy or electronic it is important that the paper is
accompanied by a letter/E-Mail message indicating the name,
address, phone number, fax number, and E-Mail of the corresponding
author and a statement that all authors have contributed to, and
read, the paper and have given permission for their name to be
included as a co-author. The letter/E-Mail must also confirm that the
manuscript has not been published and will not be submitted simulta-
neously or published elsewhere. If any illustrations, diagram or part of
the text have been published elsewhere the source must be given in
full, permissionbyhavingbeengrantedby theauthor and thepublisher.
A separate covering letter, signed by the corresponding author on
behalf of all the named authors, affirming their contribution to and
responsibility for the paper, should also be sent by regular mail or fax.
When a manuscript is accepted we require a hard copy and
electronic version which must match the hard copy exactly. Always
keep a backup copy of the electronic file for reference and safety.
Label storage media with your name, journal title, and software
used. Save your files using the default extension of the program used.
The text should be in single-column format. Keep the layout of the
text as simple as possible. Most formatting codes will be removed and
replaced on processing the article. In particular, do not use the
wordprocessor’s options to justify text or to hyphenate words.
However, do use bold face, italics, subscripts, superscripts etc. Do
not embed ‘graphically designed’ equations or tables, but prepare
these using the wordprocessor’s facility. When preparing tables, if
you are using a table grid, use only one grid for each individual table
and not a grid for each row. If no grid is used, use tabs, not spaces, to
align columns. The electronic text should be prepared in a way very
similar to that of conventional manuscripts (see also the Author
Gateway’s Quickguide: http://authors.elsevier.com). Do not import
the figures into the text file but, instead, indicate their approximate
locations directly in the electronic text and on the manuscript. To
avoid unnecessary errors you are strongly advised to use the ‘spell-
checker’ function of your wordprocessor. No changes to the accepted
version are permissible without the explicit approval of the Editor.
Electronic files can be stored on 3½ inch diskette, ZIP-disk or CD
(either MS-DOS or Macintosh).
The Editor reserves the right to make editorial and literary correc-
tions. No major alterations or corrections will be made without the
knowledge and consent of the author.
All clinical studies should contain within the text of each manu-
script a statement that all experimental protocols have been
approved by the Ethical Committee of the Institution. All patients,
or their guardians, must have given their consent after they have
received appropriate information. In the case of experimental animal
studies, similar Ethical Committee approval of the protocols must
have been obtained before the start of the studies.
Authors are encouraged to write concisely and the text should read
easily. Unnecessary experimental detail should be avoided, but
appropriate references should be given. All abbreviations should
be spelled out in full the first time they are mentioned. For drugs
and chemicals, the generic name should be used, but trade names
may follow in brackets.
The language of the journal is English (UK), for example, haema-
tology, anaesthetic, centre, paediatric.
All manuscripts are peer-reviewed. On receipt of the first decision
letter authors should send their revised manuscript within three
months in order to ensure that the scientific content of their manu-
script is timely and up to date.
Preparation of Manuscripts
Title page: The first page should be the title page, and must include
the title of the article, names, initials and appointment of each
author, name of the department(s) and institution(s) to which the
work should be attributed and name, address, phone/fax and e-mail
details of the author for correspondence and to whom reprints should
be sent. Please note that it is essential to include the email address
of the corresponding author as proofs will be sent by email as
attached PDF files.
Keywords: Include up to 10 keywords.
Abstract: The second page should carry an abstract of not more than
200 words. It need not be formally structured, and should be easy to
read, but must include the purpose of the study, basic procedures,
main findings and the principal conclusions.
Text: This should start on the third page, and will normally be divided
into the following sections: Introduction, Materials (or Patients) and
Methods, Results, Discussion and Conclusions, but other descriptive
headings and subheadings may be used if they are felt to be more
appropriate.
The introduction should explain the purpose of the study or
investigation, the clinical relevance and the background provided
by previous research or publications in this area, and, where appro-
priate, a statement of approval by an ethics committee.
Materials (or Patients) and Methods should give details of inclusion
and exclusion criteria for patients in clinical trials, research meth-
odology, systems of assessment or measurement with appropriate
references and the statistical analysis used. Any equipment or appa-
ratus used should be named, along with the manufacturer’s name and
address. Sufficient detail should be given to allow other investigators
to repeat the study. Where relevant, tables or figures may be
included to provide information more clearly. No data should nor-
mally be presented in this section.
Results should give all the relevant data, presented in a concise and
meaningful way, with tables or figures to present data more clearly or
concisely where appropriate. In studies with well under 100 subjects,
percentages should be avoided.
Discussion should consider the results and possible confounding
factors, sources of bias, weaknesses in the study, and a review of the
relevant literature, putting the results of the study in the context of
previous work in this area.
Conclusions must be based on the results presented.
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Tables: Each Table, with an appropriately brief title, should be
numbered and printed on a separate page. No vertical lines should
be used. All tables should be referred to by number in the text.
Figures: Figures must be clearly numbered. Photographic illustra-
tions should be submitted in the form of good quality prints (not
negatives or 0 slides), approximately 12 cm 18 cm (500  700). On the
back of these, on a sticky label, should be an indication of orientation
(Top), the figure number, running title and first author. Figures
should be limited to those considered essential. Colour illustrations
incur an additional cost to the author and should only be used if they
illustrate important points not demonstrable in black and white. Line
drawings should be professionally drawn with lettering large enough
to stand reduction. A list of legends for each figure must be supplied
on a separate sheet of the manuscript. Figures will not be returned
after publication. All illustrations should be referred to in the text.
Preparation of electronic illustrations
Submitting your artwork in an electronic format helps us to produce
your work to the best possible standards, ensuring accuracy, clarity
and a high level of detail.
 Always supply high-quality printouts of your artwork, in case
conversion of the electronic artwork is problematic.
 Make sure you use uniform lettering and sizing of your original
artwork.
 Save text in illustrations as ‘‘graphics’’ or enclose the font.
 Only use the following fonts in your illustrations: Arial, Courier,
Helvetica, Times, Symbol.
 Number the illustrations according to their sequence in the text.
 Use a logical naming convention for your artwork files, and supply a
separate listing of the files and the software used.
 Provide all illustrations as separate files and as hardcopy printouts
on separate sheets.
 Provide captions to illustrations separately.
 Produce images near to the desired size of the printed version.
Files can be stored on 3½ inch diskette, ZIP-disk or CD (either MS-DOS
or Macintosh).
A detailed guide on electronic artwork is available on our website:
http://authors.elsevier.com/artwork
Colour Reproduction
Submit colour illustrations as original photographs, high-quality com-
puter prints or transparencies, close to the size expected in publica-
tion, or as 35 mm slides. Polaroid colour prints are not suitable. If,
together with your accepted article, you submit usable colour
figures then Elsevier will ensure, at no additional charge, that
these figures will appear in colour on the web (e.g., ScienceDirect
and other sites) regardless of whether or not these illustrations
are reproduced in colour in the printed version. For colour repro-
duction in print, you will receive information regarding the costs from
Elsevier after receipt of your accepted article.
Please note: Because of technical complications which can arise by
converting colour figures to ‘grey scale’ (for the printed version
should you not opt for colour in print) please submit in addition
usable black and white prints corresponding to all the colour illus-
trations.
References: Authors are strongly encouraged to check the accuracy
of each reference against its original source.
All references listed at the end of the article must be cited in the
text. The references should be listed in the Reference section in
alphabetical order and numbered in alphabetical sequence, e.g. [1]
Abbott C. [2] Bader, G. [3] Brown, T. etc. References should be
indicated in the text by numbers with square brackets, e.g. [1] or
[3,8]. Where a reference is citedmore than once in the text, the same
number should be used each time. References should take the
following form:
[1] Mackay D, Wood L, Rangan A. The treatment of isolated ulnar
fractures in adults: a systematic review. Injury 2000; 31 565—73
[2] Richards RR, Corley FG. Fractures of the Shafts of the Radius and
Ulna. In: Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD.
Fractures in Adults. 4th ed. Philadelphia: Lippincott 1996 869—928
[3] Rockwood CA Jr, Green DP, Bucholz RW, Heckman JD. Fractures in
Adults. 4th ed. Philadelphia: Lippincott 1996
The titles of journals should be abbreviated as in Index Medicus.
If there are four or fewer authors, they should all be listed; if there
are five or more, the first three authors should be listed, followed by
et al.
Abbreviations and units of measurement should all be in SI units
except for measurements of blood pressure where mm Hg is pre-
ferred. For more detailed recommendations authors should consult
Baron D.N. (ed.) (1977) Units Symbols and Abbreviations: A Guide for
Biological and Medical Editors and Authors, 3rd Ed. London, Royal
Society of Medicine.
Supplementary data
Elsevier now accepts electronic supplementary material to support
and enhance your scientific research. Supplementary files offer the
author additional possibilities to publish supporting applications,
movies, animation sequences, high-resolution images, background
datasets, sound clips and more. Supplementary files supplied will
be published online alongside the electronic version of your article
in Elsevier web products, including ScienceDirect: http://
www.sciencedirect.com. In order to ensure that your submitted
material is directly usable, please ensure that data is provided
in one of our recommended file formats. Authors should submit
the material in electronic format together with the article and
supply a concise and descriptive caption for each file. For more
detailed instructions please visit our Author Gateway at http://
authors.elsevier.com.
Enquiries
Authors can keep a track on the progress of their accepted article,
and set up e-mail alerts informing them of changes to their manu-
script’s status, by using the ‘‘Track a Paper’’ feature of Elsevier’s
Author Gateway http://authors.elsevier.com. For privacy, informa-
tion on each article is password-protected. The author should key in
the ‘‘Our Reference’’ code (which is in the letter of acknowledge-
ment sent by the publisher on receipt of the accepted article) and
the name of the corresponding author. In case of problems or
questions, authors may contact the Author Service Department,
E-mail: authorsupport@elsevier.com.
Proofs
When your manuscript is received at the Publisher it is considered to
be in its final form. Proofs are not to be regarded as ‘drafts’.
One set of page proofs in PDF format will be sent by e-mail to the
corresponding author, to be checked for typesetting/editing. No
changes in, or additions to, the accepted (and subsequently edited)
manuscript will be allowed at this stage. Proofreading is solely your
responsibility.
A form with queries from the copy editor may accompany your
proofs. Please answer all queries and make any corrections or addi-
tions required.
The Publisher reserves the right to proceed with publication if
corrections are not communicated. Return corrections within two
working days of receipt of the proofs. Should there be no corrections,
please confirm this.
Elsevier will do everything possible to get your article corrected
and published as quickly and accurately as possible. In order to do
this we need your help. When you receive the (PDF) proof of your
article for correction, it is important to ensure that all of your
corrections are sent back to us in one communication. Subsequent
corrections will not be possible, so please ensure your first sending is
complete. Note that this does not mean you have any less time to
make your corrections, just that only one set of corrections will be
accepted.
Copyright: Authors must sign the ‘Transfer of Copyright’ agreement,
or, where the authors work for an organisation that does not permit
such assignment, a standard licence agreement, before an article
can be published. This transfer agreement enables Elsevier Ltd to
protect the copyright material for authors, but does not relinquish
the author’s proprietary rights. The copyright transfer covers the
exclusive rights to reproduce and distribute the article, including
reprints, photographic reproductions, microfilm or the right to adapt
the article for use or in conjunction with computer systems and
programs, including reproduction or publication in machine-readable
form and incorporation in retrieval systems.
